2020 Conference Publication Recombinant Adeno-Associated Virus Vector Tropism in Human RetinaAndrzejewski, Slawomir, Moyle, Peter M., Stringer, Brett W., Steel, Jason and Layton, Christopher J. (2020). Recombinant Adeno-Associated Virus Vector Tropism in Human Retina. In: 23rd Annual Meeting of the American Society for Gene and Cell Therapy, Electr Network, (254-254). 12-15 May 2020. |
2019 Conference Publication Effect of human vitreous humour components and neutralising antibodies on transduction activity of recombinant AAV2, AAV5, AAV6 and AAV8Andrzejewski, S., Moyle, P., Stringer, B., Steel, J. and Layton, C. J. (2019). Effect of human vitreous humour components and neutralising antibodies on transduction activity of recombinant AAV2, AAV5, AAV6 and AAV8. Annual Conference of the British-Society-for-Gene-and-Cell-Therapy, Sheffield, United Kingdom , 19-21 June 2019. New Rochelle, NY, United States: Mary Ann Liebert. |
2019 Conference Publication Production of liposomes using supercritical fluid technology and active targeting peptide to a gastrointestinal receptor in cancer cellsMaqbool, Faheem, Moyle, Peter M. and Falconer, James R. (2019). Production of liposomes using supercritical fluid technology and active targeting peptide to a gastrointestinal receptor in cancer cells. Controlled Release Society (CRS), Valencia, Spain, 21-24 July 2019. |
2018 Conference Publication Novel preparation of proliposomes with various phospholipids in Supercritical Carbon DioxideMaqbool, Faheem, Moyle, Peter M. and Falconer, James R. (2018). Novel preparation of proliposomes with various phospholipids in Supercritical Carbon Dioxide. Controlled Release Society (CRS), New York City, United States, 22-25 July 2018. |
2017 Conference Publication A static and gravimetric method for the determination of solubility of Albendazole and its characterization in supercritical carbon dioxideMaqbool, Faheem, Moyle, Peter M. and Falconer, James R. (2017). A static and gravimetric method for the determination of solubility of Albendazole and its characterization in supercritical carbon dioxide. Drug Delivery Australia (DDA), Wollongong, Australia, 23-24 October 2017. |
2009 Conference Publication Vaccine delivery utilizing liposaccharidesSimerska, Pavla, McGeary, Ross P., Abdel-Aal, Abu-Baker M., Moyle, Peter M., Olive, Colleen, Good, Michael F. and Toth, Istvan (2009). Vaccine delivery utilizing liposaccharides. The 20th American Peptide Symposium, Montreal, Canada, 26-30 June, 2007. United States: Springer. doi: 10.1007/978-0-387-73657-0_153 |
2009 Conference Publication Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidateToth, Istvan, Moyle, Peter M., Simerska, Pavla, Fujita, Yoshio, Olive, Colleen and Good, Michael F. (2009). Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate. 20th American Peptide Symposium, Montréal, Quebec, Canada, 26-30 June 2007. New York: Springer. doi: 10.1007/978-0-387-73657-0_154 |
2008 Conference Publication Investigation toward multi-epitope vaccine candidates using native chemical ligationFujita, Yoshio, Moyle, Peter M., Hieu, Suzanne, Simerska, Pavla and Toth, Istvan (2008). Investigation toward multi-epitope vaccine candidates using native chemical ligation. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/bip.21002 |
2007 Conference Publication Peptide-lipid-carbohydrate based vaccine against group A Streptococcal infection.Simerska, P., Abdel-Aal, A. B., McGeary, R., Moyle, P.M., Fujita, Y., Good, M.F. and Toth, I. (2007). Peptide-lipid-carbohydrate based vaccine against group A Streptococcal infection.. 13th International Congress of Immunology, Rio de Janeiro, Brazil, August 21-25. |
2007 Conference Publication Development of a Multivalent Heteroepitopic Group A Streptococcus VaccineFujita, Y., Moyle, P., Abdel-Aal, A., Batzloff, M., Good, M. and Toth, I. (2007). Development of a Multivalent Heteroepitopic Group A Streptococcus Vaccine. 4th International Peptide Symposium, Cairns, 21-25 October 2007. Australia: Australian Peptide Association. |
2007 Conference Publication Vaccine Delivery Utilizing LiposaccharidesSimerska, P., Moyle, P. M., Zhong, W., McGeary, R., Abdel-Aal, A. B., Good, M. F. and Toth, I. (2007). Vaccine Delivery Utilizing Liposaccharides. 20th American Peptide Symposium, Montréal, Quebec, Canada, 26-30 June 2007. Hoboken: John Wiley & Sons. doi: 10.1002/bip.20783 |
2007 Conference Publication Novel lipoamino acid based vaccine adjuvant carrier systemToth, I., Moyle, P. M., Simerska, P., Fujita, Y., Olive, C. and Good, M. F. (2007). Novel lipoamino acid based vaccine adjuvant carrier system. International Congress of Immunology, Rio de Janeiro, Brazil, 21-25 August 2007. Toronto, Canada: Hogrefe & Huber. |
2007 Conference Publication Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidateToth, I., Moyle, P. M., Simerska, P., Fujita, Y., Olive, C. and Good, M. F. (2007). Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate. 20th American Peptide Symposium, Montréal, Quebec, Canada, 26-30 June 2007. HOBOKEN: Wiley Periodicals. doi: 10.1002/bip.20783 |
2007 Conference Publication Liposaccharides in Peptide Vaccine DeliverySimerska, P., Moyle, P. M., Abdel-Aal, A. M., Fujita, Y., Olive, C., Batzloff, M. R., Good, M. F. and Toth, I. (2007). Liposaccharides in Peptide Vaccine Delivery. 4th International Peptide Symposium, Cairns, 21-25 October 2007. Australia: Australian Peptide Association. |
2006 Conference Publication Liposaccharides in peptide, gene and vaccine deliveryToth, I., Moyle, P. M., Simerska, P., Fujita, Y., Olive, C. and Good, M. F. (2006). Liposaccharides in peptide, gene and vaccine delivery. Drug Design Amongst the Vines, Hunter Valley, 3 - 7 December, 2006. |
2006 Conference Publication Highly pure, multi-epitopic lipopeptide vaccine delivery system: Synthesis and investigationMoyle, P. M., Olive, C., Ho, M.-F., Good, M F and Toth, I (2006). Highly pure, multi-epitopic lipopeptide vaccine delivery system: Synthesis and investigation. Brisbane Biological & Organic Chemistry Symposium, Brisbane, 24 Nov 2006. |
2006 Conference Publication Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancerSimerska, P., Moyle, P. M., Olive, C., Sun, H. K., Ho, M. F., Pandy, M. G., Dyer, J. R., Burgess, M. L. and Toth, I. (2006). Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer. GPEN 2006, Lawrence, USA, 25-27 October, 2006. |
2006 Conference Publication Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococciMoyle, Peter M., Horvath, Aniko, Karpati, Levente, Olive, Colleen, Barozzi, Nadia, Wimmer, Norbert, Good, Michael and Toth, Istvan (2006). Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococci. 19th American Peptide Symposium, San Diego, United States, 18-23 June 2005. New York, United States: Springer. doi: 10.1007/978-0-387-26575-9_169 |
2006 Conference Publication Liposaccharides in peptide, gene and vaccine deliveryToth, I, Moyle, P. M., Koda, Y., Olive, C. and Good, M F (2006). Liposaccharides in peptide, gene and vaccine delivery. 10th Naples Workshop on Bioactive Peptides, Naples, 11-14 June, 2006. |
2006 Conference Publication Multi-epitopic lipid core peptide vaccine with broad protective immune responses against Group A StreptococcusFujita, Y., Moyle, P., Olive, C., Good, M. and Toth, I. (2006). Multi-epitopic lipid core peptide vaccine with broad protective immune responses against Group A Streptococcus. CHICHESTER: JOHN WILEY & SONS LTD. |